MeiraGTx Holdings MGTX
NASDAQ MGTX
$13.89 -0.08 (-0.57%)
As of: Sep 4, 2026 · 3:59 PM EDT

MeiraGTx Holdings (MGTX) Other Non-Current Assets (2017 - 2026)

MeiraGTx Holdings' (MGTX) quarterly Other Non-Current Assets came in at $1.1 million in Q4 2025, up 14.47% YoY from $1.0 million in Q4 2024, and down 49.36% on a QoQ basis from $2.3 million in Q3 2025.

Analysis

MeiraGTx Holdings (MGTX) Other Non-Current Assets (2017 - 2026) Analysis & Trends

MeiraGTx Holdings (MGTX) has 9 years of Other Non-Current Assets data on file, last reported at $1.1 million in Q4 2025.

  • Quarterly Other Non-Current Assets rose 14.47% year-over-year to $1.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.1 million (up 14.47% YoY) and the FY2025 annual result came in at $1.1 million, up 14.47% from the prior year.
  • Other Non-Current Assets slipped to $1.1 million in Q4 2025, from $2.3 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $2.3 million in Q3 2025 to a low of $682000.0 in Q3 2022.
  • A 5-year average of $1.3 million and a median of $1.1 million in 2023 frame the typical range for Other Non-Current Assets.
  • Annual changes were most pronounced in 2023 — Other Non-Current Assets tumbled 49.97% — and 2025, when it surged 98.86%.
  • Tracing MGTX's Other Non-Current Assets over 5 years: stood at $783000.0 in 2021, then jumped by 79.05% to $1.4 million in 2022, then slipped by 22.75% to $1.1 million in 2023, then slipped by 7.48% to $1.0 million in 2024, then increased by 14.47% to $1.1 million in 2025.
  • The last three Other Non-Current Assets figures came in at $1.1 million (Q4 2025), $2.3 million (Q3 2025), and $2.3 million (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.25 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 2.31 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 124.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 618.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 42.45 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 109.58 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 65.13 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 62.96 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 104.44 Mn
10 MeiraGTx Holdings 1.27 Bn 1.13 Bn 315.67 Mn 2.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.20 Mn
Dec 31, 2025 2.26 Mn
Sep 30, 2025 2.27 Mn
Jun 30, 2025 2.26 Mn
Mar 31, 2025 2.09 Mn
Dec 31, 2024 2.01 Mn
Sep 30, 2024 2.16 Mn
Jun 30, 2024 1.14 Mn
Mar 31, 2024 1.14 Mn
Dec 31, 2023 1.92 Mn
Sep 30, 2023 1.42 Mn
Jun 30, 2023 1.47 Mn
Mar 31, 2023 1.43 Mn
Dec 31, 2022 1.40 Mn
Sep 30, 2022 1.32 Mn
Jun 30, 2022 1.51 Mn
Mar 31, 2022 1.61 Mn
Dec 31, 2021 1.40 Mn
Sep 30, 2021 1.17 Mn
Jun 30, 2021 1.20 Mn